Sector Experience
Industry Expertise
Cross-sector executive experience enabling commercial insight, CSO discipline, and strategic perspective across diverse organisational environments.
Andrew Burgess brings extensive sector experience across Pharmaceuticals & Life Sciences, Drug Development & R&D, Respiratory & Inhalation, Pharmaceutical Manufacturing & Operations, Medical Devices & Drug Delivery, Strategic Sourcing & Procurement, Packaging, Raw Materials & Excipients, CDMO & Strategic Partnerships, Scientific & Technology Development, Supply Chain & Supplier Management, and Commercialization & Product Lifecycle Management.
Pharmaceuticals & Life Sciences
35+ years across scientific leadership, R&D, formulation, drug development, procurement, manufacturing, and commercialization.
Respiratory Pharmaceuticals
pMDI, DPI, inhalation formulation, respiratory drug development, and respiratory delivery technologies.
Drug Development & Therapeutics
pre-clinical development, proof of concept, respiratory therapies, drug repurposing, and paediatric Eosinophilic Esophagitis.
Pharmaceutical Manufacturing & Supply
global manufacturing, supply strategy, supply continuity, risk management, and operational performance.
Pharmaceutical Procurement & Strategic Sourcing
global sourcing, category management, supplier strategy, contract management, packaging, raw materials, excipients, and laboratory procurement.
Medical Devices & Drug Delivery
auto-injectors, respiratory devices, pharmaceutical delivery systems, R&D-to-commercial launch, and a portfolio of approximately $500M in spend.
CDMO & External Partnerships
CDMO programme design, negotiation, pre-clinical development, proof of concept, and strategic scientific alliances.
Packaging, Raw Materials & Excipients
regional and global category leadership across pharmaceutical packaging, raw materials, and excipients.
Scientific & Formulation Development
analytical chemistry, formulation development, inhalation products, oral solid dose, pMDI, and DPI technologies.
R&D Procurement & Laboratory Operations
global UK/US R&D sourcing, laboratory supplies and equipment, supplier relationship management, and research infrastructure.
Strategic Transformation & Operational Excellence
procurement transformation, supplier consolidation, governance, supply-risk management, acquired-site integration, and continuous improvement.
Capital Investment & Enterprise Value Creation
including the Lactose New Zealand project, $35M funding proposal, CEO-level investment consideration, and asset valuation improvement.
Business Development & Commercial Strategy
strategic alliances, commercial negotiations, technical evaluation, investment considerations, and pharmaceutical growth initiatives.
Organizational Value
Why Organizations Engage Andrew
Andrew is engaged by organizations because he connects scientific expertise with commercial and operational execution. He helps organizations turn pharmaceutical innovation into practical business value through scientific strategy, strategic partnerships, procurement transformation, operational improvement, and disciplined investment.
His experience also brings a strong focus on value creation, risk management, supply resilience, and executive decision-making, supported by measurable results across pharmaceutical R&D, manufacturing, sourcing, and strategic initiatives.
